Although GM-CSF cellular vaccines are not used in the clinic for PC, this cytokine is widely used in combination therapies and other PC vaccines in preclinic studies and research on GM-CSF in PC treatment is ongoing (108). The gene discussed is CSF2; the disease is pachyonychia congenita.